Exicure, Inc. Enters Into Definitive Agreement With Cbi Usa, Inc. For $5.4 Million Equity Financing And Announces Implementation Of Strategic Measure To Reduce Cash Burn And Prioritize Strategic Alternatives
Exicure, Inc. Enters Into Definitive Agreement With Cbi Usa, Inc. For $5.4 Million Equity Financing And Announces Implementation Of Strategic Measure To Reduce Cash Burn And Prioritize Strategic Alternatives
09/26/22, 8:04 PM
Location
chicagoMoney raised
$5.4 million
Exicure, Inc. (NASDAQ: XCUR) today announced plans to restructure the Company and align resources to continue exploring strategic alternatives that maximize stockholder value. After a strategic review of the Company’s business plans and objectives and its existing cash resources, the Company’s Board of Directors has approved the following:
Company Info
Location
n halsted street
chicago, illinois, united states
Additional Info
Exicure, Inc. is an early-stage biotechnology company developing nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. The team includes a diverse scientific group with expertise in nucleic acid chemistry, drug development, and neuroscience. For further information, see www.exicuretx.com.